Current Treatment and Future Developments in the Treatment of Amyloidosis

Washington University cardiologist at Barnes-Jewish Hospital, Daniel Lenihan, MD, presents a contemporary update of the diagnosis, epidemiology and current treatment available for cardiac amyloidosis. Several items are emphasized including the common noninvasive techniques to confirm the diagnosis and the utility of cardiac biopsy as part of the evaluation. Additionally, the latest clinical trials—particularly for novel new therapies for TTR amyloidosis—were highlighted.

Related Presenters

Daniel Lenihan, MD.

Daniel Lenihan, MD

Professor of Medicine
Director, Cardio-Oncology Center of Excellence,
Washington University School of Medicine
St. Louis, MO

Education Daniel Lenihan, MD, is a cardio-oncologist who specializes in cardiology, heart disease and advanced heart failure/cardiac transplant. His areas of interest include cardiotoxicity of cancer therapy, early phase clinical trials, ...

View full profile